Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiency

Willemijn J van Rijt, Johan L K Van Hove, Frédéric M Vaz, Rick Havinga, Derk P Allersma, Tanja R Zijp, Jirair K Bedoyan, M Rebecca Heiner-Fokkema, Dirk-Jan Reijngoud, Michael T Geraghty, Ronald J A Wanders, Maaike H Oosterveer, Terry G J Derks*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Downloads (Pure)

Abstract

D,L-3-hydroxybutyrate (D,L-3-HB, a ketone body) treatment has been described in several inborn errors of metabolism, including multiple acyl-CoA dehydrogenase deficiency (MADD; glutaric aciduria type II). We aimed to improve the understanding of enantiomer-specific pharmacokinetics of D,L-3-HB. Using UPLC-MS/MS, we analyzed D-3-HB and L-3-HB concentrations in blood samples from three MADD patients, and blood and tissue samples from healthy rats, upon D,L-3-HB salt administration (patients: 736-1123 mg/kg/day; rats: 1579-6317 mg/kg/day of salt-free D,L-3-HB). D,L-3-HB administration caused substantially higher L-3-HB concentrations than D-3-HB. In MADD patients, both enantiomers peaked at 30-60 minutes, and approached baseline after three hours. In rats, D,L-3-HB administration significantly increased Cmax and AUC of D-3-HB in a dose-dependent manner (controls vs. ascending dose groups for Cmax : 0.10 vs. 0.30-0.35-0.50 mmol/L, and AUC: 14 vs. 58-71-106 min*mmol/L), whereas for L-3-HB the increases were significant compared to controls, but not dose proportional (Cmax : 0.01 vs. 1.88-1.92-1.98 mmol/L, and AUC: 1 vs. 380-454-479 min*mmol/L). L-3-HB concentrations increased extensively in brain, heart, liver and muscle, whereas the most profound rise in D-3-HB was observed in heart and liver. Our study provides important knowledge on the absorption and distribution upon oral D,L-3-HB. The enantiomer-specific pharmacokinetics implies differential metabolic fates of D-3-HB and L-3-HB. This article is protected by copyright. All rights reserved.

Original languageEnglish
Number of pages13
JournalJournal of Inherited Metabolic Disease
DOIs
Publication statusE-pub ahead of print - 5-Feb-2021

Keywords

  • 3&#8208
  • hydroxybutyrate
  • enantiomer
  • inborn error of metabolism
  • ketone bodies
  • multiple acyl&#8208
  • CoA dehydrogenase deficiency
  • pharmacokinetics

Cite this